(Blogmensgo, gay blog of February 25, 2016) Today, the 23rd Conference on Retroviruses and Opportunistic Infections (CROI) is ending in Boston. As in the years before, renowned experts from around the globe have gathered since February 22.
Just like two years ago, the big multinational pharmaceutical corporations that work in this field sponsored the international conference.
A vaccine for prophylactic or curative treatment? It looks like this goal has become much more tangible this year.
This year, the experts have focused on the very ambitious UNAIDS (Joint United Nations Programme on HIV/AIDS) goal “90-90-90”: 90% of all seropositive people should be diagnosed, of whom 90% should be on antiretroviral treatment, of whom 90% should have an undetectable viral load. This means they can be kept in good health and are (almost) not contagious anymore. Other subjects include hepatitis C, pre-exposure prophylaxis (PrEP), cancer, cardiovascular diseases and funding of research and therapies.
Like in the years before, the British organization NAM via their project Aidsmap (see link on top of page) offers a lot of information on the event free of charge.
During and after the conference, Aidsmap once again offers electronic newsletter in six languages (English, Spanish, French, Italian, Portuguese and Russian).
This makes the very difficult-to-understand presentations and speeches comprehensible for a large audience.
Frank-S / MensGo
(Via Aidsmap, e-Mail of February 19, 2016)